{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:41:26Z","timestamp":1788234086111,"version":"build-2803163510"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"\n Objective<\/jats:title>\n As a metabolic disease, one important feature of non-alcoholic fatty liver disease (NAFLD) is the disturbance of the intestinal flora. Spleen-strengthening and liver-draining formula (SLF) is a formula formed according to the theory of \u201cOne Qi Circulation\u201d (Qing Dynasty, 1749) of Traditional Chinese Medicine (TCM), which has shown significant therapeutic effect in patients with NAFLD in a preliminary clinical observation. In this study, we aim to explore the mechanism of SLF against NAFLD, especially its effect on glucolipid metabolism, from the perspective of intestinal flora.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A prospective, randomized, controlled clinical study was designed to observe the efficacy and safety of SLF in the treatment of NAFLD. The study participants were randomly and evenly divided into control group and treatment group (SLF group). The control group made lifestyle adjustments, while the SLF group was treated with SLF on top of the control group. Both groups were participated in the study for 12 consecutive weeks. Furthermore, the feces of the two groups were collected before and after treatment. The intestinal flora of each group and healthy control (HC) were detected utilizing 16S rRNA gene sequencing.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Compared with the control group, the SLF group showed significant improvements in liver function, controlled attenuation parameter (CAP), and liver stiffness measurement (LSM), meanwhile, patients had significantly lower lipid and homeostasis model assessment of insulin resistance (HOMA-IR) with better security. Intestinal flora 16S rRNA gene sequencing results indicated reduced flora diversity and altered species abundance in patients with NAFLD. At the phylum level,\n Desulfobacterota<\/jats:italic>\n levels were reduced. Although\n Firmicutes<\/jats:italic>\n and\n Bacteroidetes<\/jats:italic>\n did not differ significantly between HC and NAFLD, when grouped by alanine transaminase (ALT) and aspartate transaminase (AST) levels in NAFLD,\n Firmicutes<\/jats:italic>\n levels were significantly higher in patients with ALT or AST abnormalities, while\n Bacteroidetes<\/jats:italic>\n was significantly lower. Clinical correlation analysis showed that\n Firmicutes<\/jats:italic>\n positively correlated with gender, age, ALT, AST, LSM, and Fibroscan-AST (FAST) score, while the opposite was true for\n Bacteroidetes<\/jats:italic>\n . At the genus level, the levels of\n Alistipes<\/jats:italic>\n ,\n Bilophila<\/jats:italic>\n ,\n Butyricimonas<\/jats:italic>\n ,\n Coprococcus<\/jats:italic>\n ,\n Lachnospiraceae_NK4A136<\/jats:italic>\n group\n Phascolarctobacterium<\/jats:italic>\n ,\n Ruminococcus<\/jats:italic>\n ,\n UCG-002<\/jats:italic>\n , and\n UCG-003<\/jats:italic>\n were reduced, whereas abundance of\n Tyzzerella<\/jats:italic>\n increased. There was no statistically significant difference in\n Firmicutes<\/jats:italic>\n and\n Bacteroidota<\/jats:italic>\n levels in the SLF group before and after treatment, but both bacteria tended to retrace. At the genus level,\n Coprococcus<\/jats:italic>\n (\n Lachnospiraceae<\/jats:italic>\n family),\n Lachnospiraceae_NK4A136 group<\/jats:italic>\n (\n Lachnospiraceae<\/jats:italic>\n family), and\n Ruminococcus<\/jats:italic>\n (\n Ruminococcaceae<\/jats:italic>\n family) were significantly higher in the SLF group after treatment, and there was also a tendency for\n Bilophila<\/jats:italic>\n (\n Desulfovibrionaceae<\/jats:italic>\n family) to be back-regulated toward HC.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n SLF can improve liver function and glucolipid metabolism in patients with NAFLD and lower down liver fat content to some extent. SLF could be carried out by regulating the disturbance of intestinal flora, especially\n Coprococcus<\/jats:italic>\n ,\n Lachnospiraceae_NK4A136<\/jats:italic>\n group, and\n Ruminococcus<\/jats:italic>\n genus.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fendo.2022.1107071","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T02:39:13Z","timestamp":1674095953000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial"],"prefix":"10.3389","volume":"13","author":[{"given":"Dengcheng","family":"Hui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisma Lena Bahaji","family":"Azami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism: Clin Exp"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"New Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: The state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2020.11.010","article-title":"Current concepts, opportunities, and challenges of gut microbiome-based personalized medicine in nonalcoholic fatty liver disease","volume":"33","author":"Sharpton","year":"2021","journal-title":"Cell Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3760\/cma.j.issn.1007-3418.2018.03.008","article-title":"[Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update]","volume":"26","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.3202","article-title":"Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: A randomized clinical trial","volume":"176","author":"Zhang","year":"2016","journal-title":"JAMA Intern Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e3283547157","article-title":"Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease","volume":"15","author":"Schugar","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-resolution sample inference from illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41587-019-0252-6","article-title":"Author correction: Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0548-6","article-title":"PICRUSt2 for prediction of metagenome functions","volume":"38","author":"Douglas","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B12","article-title":"The mental health of newly graduated doctors in Malta","author":"Taylor-East","year":"2013","journal-title":"Psychiatr Danub"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i34.12082","article-title":"Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic","volume":"20","author":"Hassan","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03538.x","article-title":"Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis","volume":"27","author":"Tsochatzis","year":"2008","journal-title":"Alimentary Pharmacol Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2015.05.009","article-title":"Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial","volume":"99","author":"Chen","year":"2015","journal-title":"Pharmacol Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-019-0331-1","article-title":"Nano-curcumin improves glucose indices, lipids, inflammation, and nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial","volume":"16","author":"Jazayeri-Tehrani","year":"2019","journal-title":"Nutr Metab (Lond)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/microorganisms8040527","article-title":"Role of gut microbiota in neuroendocrine regulation of carbohydrate and lipid metabolism via the microbiota-Gut-Brain-Liver axis","volume":"8","author":"Wang","year":"2020","journal-title":"Microorganisms"},{"key":"B21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/ijms17040481","article-title":"Diet, microbiota, obesity, and NAFLD: A dangerous quartet","volume":"17","author":"Machado","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i42.15518","article-title":"Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease","volume":"20","author":"Paolella","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26319","article-title":"Intestinal microbiota in patients with nonalcoholic fatty liver disease","volume":"58","author":"Mouzaki","year":"2013","journal-title":"Hepatol (Baltimore Md)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00518","article-title":"Metagenome of gut microbiota of children with nonalcoholic fatty liver disease","volume":"7","author":"Zhao","year":"2019","journal-title":"Front Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cmet.2019.08.002","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"30","author":"Loomba","year":"2019","journal-title":"Cell Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28829","article-title":"Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis","volume":"64","author":"Lelouvier","year":"2016","journal-title":"Hepatol (Baltimore Md)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-2061-5","article-title":"Gut microbiota and obesity","volume":"73","author":"G\u00e9rard","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00611","article-title":"Gut dysfunction and non-alcoholic fatty liver disease","volume":"10","author":"Grabherr","year":"2019","journal-title":"Front Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatol (Baltimore Md)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobil Pancreat Dis Int"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.19540\/j.cnki.cjcmm.20181101.013","article-title":"[Regulatory effect of traditional Chinese medicine on intestinal microbiota]","volume":"44","author":"Yu","year":"2019","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chin materia Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"112806","DOI":"10.1016\/j.jep.2020.112806","article-title":"Multi-omics reveals the mechanisms of antidepressant-like effects of the low polarity fraction of bupleuri radix","volume":"256","author":"Feng","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"115365","DOI":"10.1016\/j.jep.2022.115365","article-title":"Aqueous extract of paeoniae radix alba (Paeonia lactiflora pall.) ameliorates DSS-induced colitis in mice by tunning the intestinal physical barrier, immune responses, and microbiota","volume":"294","author":"Yan","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"109019","DOI":"10.1016\/j.jnutbio.2022.109019","article-title":"Regulation of gut microbiota and intestinal metabolites by poria cocos oligosaccharides improves glycolipid metabolism disturbance in high-fat diet-fed mice","volume":"107","author":"Zhu","year":"2022","journal-title":"J Nutr Biochem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2019.0042","article-title":"Combination of probiotics and polysaccharide alleviates hepatic steatosis via gut microbiota modulation and insulin resistance improvement in high fat-induced NAFLD mice","volume":"44","author":"Wang","year":"2020","journal-title":"Diabetes Metab J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"926381","DOI":"10.1155\/2014\/926381","article-title":"The metabolism of polysaccharide from atractylodes macrocephala koidz and its effect on intestinal microflora","volume":"2014","author":"Wang","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax6208","article-title":"Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism","volume":"6","author":"Zeng","year":"2020","journal-title":"Sci Adv"},{"key":"B39","doi-asserted-by":"publisher","first-page":"121110","DOI":"10.1016\/j.lfs.2022.121110","article-title":"Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet","volume":"310","author":"Wang","year":"2022","journal-title":"Life Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1039\/D2FO00836J","article-title":"Procyanidins from hawthorn alleviate lipid metabolism disorder inhibiting insulin resistance and oxidative stress, normalizing the gut microbiota structure and intestinal barrier, and further suppressing hepatic inflammation and lipid accumulation","volume":"13","author":"Han","year":"2022","journal-title":"Food Funct"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e634","DOI":"10.1002\/ctm2.634","article-title":"Lactobacillus lactis and pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease","volume":"11","author":"Yu","year":"2021","journal-title":"Clin Transl Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1039\/D0FO00795A","article-title":"Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD","volume":"11","author":"Xie","year":"2020","journal-title":"Food Funct"},{"key":"B43","doi-asserted-by":"publisher","first-page":"110467","DOI":"10.1016\/j.foodres.2021.110467","article-title":"Regulatory effects of lactobacillus fermented black barley on intestinal microbiota of NAFLD rats","volume":"147","author":"Zhu","year":"2021","journal-title":"Food Res Int"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41598-018-19753-9","article-title":"Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance","volume":"8","author":"Da Silva","year":"2018","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1039\/D1FO00078K","article-title":"Effect of soybean insoluble dietary fiber on prevention of obesity in high-fat diet fed mice via regulation of the gut microbiota","volume":"12","author":"Wang","year":"2021","journal-title":"Food Funct"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3390\/nu14112208","article-title":"Prevention of ulcerative colitis in mice by sweet tea via the regulation of gut microbiota and butyric-Acid-Mediated anti-inflammatory signaling","volume":"14","author":"He","year":"2022","journal-title":"Nutrients"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1107071\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T02:39:18Z","timestamp":1674095958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1107071\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":46,"alternative-id":["10.3389\/fendo.2022.1107071"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1107071","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]},"article-number":"1107071"}}